AI is enhancing clinician precision, says Philips North America CEO

Deep News
06/10

A survey sponsored by Royal Philips NV indicates that artificial intelligence is aiding in the improvement of patient care accuracy and, in some instances, saving time and costs, according to the CEO of the company's North American division.

Jeff DiLullo, the CEO of Philips North America, noted that over time, this technology will transform the role of clinicians in healthcare, specifically highlighting gains in labor productivity.

"The median number of additional patients they can see per week is five," DiLullo stated. "This has economic implications for the healthcare system."

The Philips "Future Health Index" survey was conducted by research consultancy Vitreous World between February and April, covering respondents in 10 countries, including 2,011 clinicians and 20,085 patients.

Approximately 30% of the responding physicians reported that AI has already helped them save on their budgets.

Among clinicians, 27% said AI helped them identify potential medical errors at least three times in the past three months, while 36% reported that AI increased their weekly patient capacity. However, 77% of the surveyed clinicians indicated that AI training is either unavailable, limited, or inconsistent.

The Netherlands-based Royal Philips NV stated that healthcare professionals primarily use artificial intelligence for administrative tasks like data organization and scheduling, with more complex decision-making remaining the responsibility of clinicians.

Patients are also increasingly turning to AI for health advice, though previous research has shown the technology is not more helpful than other methods when making medical decisions.

Health insurers, such as Centene, have previously expressed dissatisfaction with AI use in healthcare systems, claiming that its aggressive or improper application has led to increased reimbursement payments.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10